This is a "connection" page, showing publications co-authored by Jordan Elm and Amy DeLambo.
A Randomized Clinical Trial of Atomoxetine for Mild Cognitive Impairment in Parkinson's Disease. Mov Disord Clin Pract. 2017 May-Jun; 4(3):416-423.
Pilot study of atomoxetine in patients with Parkinson's disease and dopa-unresponsive Freezing of Gait. Transl Neurodegener. 2015; 4:24.